Kimball Electronics, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $KE in the last 7 days.
No SEC Form 4 filings for $KE in the last 30 days.
See all $KE insider activity →Kimball Electronics (KE) reported Q4 net sales of $371.6M, up 5% sequentially. Full-year sales fell 4% to $1.431B. The company expects fiscal 2027 sales of $1.535B-$1.56B, driven by medical device growth and a recent acquisition. Debt reduced to $116.6M, with $88.9M in cash. Guidance includes flat to lower margins despite higher capital spending.
Powell (POWL) reported Q2 revenue of $311.7M, up 8.9% YoY but missing estimates, with stock down 17%. Kimball Solutions (KE) reported $371.6M revenue, down 2.3% YoY, missing EPS estimates. GE Vernova (GEV) reported $11.1B revenue, up 21.9% YoY, topping estimates but missing EPS. All companies provided full-year guidance.
Kimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.
Recent KE coverage spans earnings, financial news and macro economy.
Guidance suggests modest top‑line growth but flat margins, while balance‑sheet strength and share repurchases may support the stock.
Flat price action despite earnings miss suggests limited immediate impact.
Earnings miss with modest guidance may pressure the stock short‑term, but improving cash flow and medical‑segment growth offer upside potential.
Q2 earnings data released, potential impact on stock price.
Modest insider buying and new grant may signal confidence but limited scale.
AlphAI scores every news story that mentions KE with an AI model for sentiment and relevance, and aggregates insider trades from Kimball Electronics, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Kimball Electronics (KE) reported Q4 net sales of $371.6M, up 5% sequentially. Full-year sales fell 4% to $1.431B. The company expects fiscal 2027 sales of $1.535B-$1.56B, driven by medical device growth and a recent acquisition. Debt reduced to $116.6M, with $88.9M in cash. Guidance includes flat to lower margins despite higher capital spending.
3 min readPowell (POWL) reported Q2 revenue of $311.7M, up 8.9% YoY but missing estimates, with stock down 17%. Kimball Solutions (KE) reported $371.6M revenue, down 2.3% YoY, missing EPS estimates. GE Vernova (GEV) reported $11.1B revenue, up 21.9% YoY, topping estimates but missing EPS. All companies provided full-year guidance.
2 min readKimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.
2 min readPowell reported $311.7M revenue, up 8.9% YoY, missing estimates. Stock down 11.1%. Acuity Brands reported $1.2B revenue, up 1.6%, beating estimates. Stock up 18.5%. Whirlpool reported $3.52B revenue, down 6.8%, missing EPS but beating guidance. Stock up 1.4%.
3 min readKimball Electronics (KE) CEO Richard D. Phillips exercised 40,953 restricted shares, received 58,206 new restricted shares, and had 36,277 performance-based shares vest. 30,391 shares were withheld for taxes at $22.725 per share. Phillips also holds 82,188 shares indirectly via a spousal trust. The shares vest in 2027, 2028, and 2029.
1 min readKimball Electronics (KE) reported Q4 2026 net sales of $371.6M, down 2% YoY but up 5% sequentially. Fiscal 2026 revenue was $1.431B, with medical segment growth of 11%. Adjusted operating income was $18.1M (4.9% of sales). Guidance for 2027 projects revenue of $1.535B-$1.560B, with medical sales expected to grow significantly due to the Helvoet acquisition.
3 min readThe week ahead focuses on housing and consumer health. Housing starts and pending home sales are due Tuesday, with July starts up 19% month over month and pending sales down 5.4% in June. Earnings include Home Depot (est. $47.27B revenue, $4.73 EPS) and TJX (est. $15.18B revenue, $1.19 EPS), plus Walmart and Ross commentary.
6 min readKimball Electronics (Nasdaq: KE) reported Q4 FY2026 ended June 30, 2026 net sales of $371.6M, up 5% sequentially but down 2% YoY. Operating income was $29.1M (7.8% margin). Diluted EPS was $0.35. Cash from operations was $42.4M; debt fell to $116.6M. FY2027 guidance: net sales $1.535–$1.560B, incl. ~$60M from Helvoet, and adjusted op margin 4.4%–4.7%.
4 min readKimball Electronics (NASDAQ:KE) reported fiscal Q4 2026 revenue of $372M, about on target, down 2% year over year. Adjusted EPS was -$0.01 vs $0.41 expected, with adjusted operating income $18.1M. Medical sales rose to $109M, while cash flow and debt fell. Fiscal 2027 revenue guidance is $1.535B to $1.560B.
6 min readKimball Electronics (KE) reported Q4 sales down 2% year over year but up sequentially. The company said medical is leading growth and that strong cash generation supports debt reduction. For FY 2027, it projects 7% to 9% sales growth, driven by organic gains and the Helvoet acquisition, with medical nearing 35% of total sales.
1 min read
